After SAHA treatment, α-SMA intensity was reduced, as were cardiac interstitial fibrosis, and mRNA level of FN1 and LOX when compared with β2a-HFD-LN mice (Fig. 6, A–E). The gene discussed is LOX; the disease is Interstitial cardiac fibrosis.